Suppr超能文献

乳腺癌患者主要术后并发症与生存:基于瑞典人群的 57152 名女性的注册研究。

Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women.

机构信息

Department of Surgery, Capio St Göran's Hospital, Stockholm, Sweden.

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

出版信息

Br J Surg. 2022 Sep 9;109(10):977-983. doi: 10.1093/bjs/znac275.

Abstract

BACKGROUND

Postoperative complications may activate prometastatic systemic pathways through tissue damage, wound healing, infection, and inflammation. Postoperative complications are associated with inferior survival in several types of cancer. The aim was to determine the association between postoperative complications and survival in breast cancer.

METHODS

This population-based cohort included women operated for T1-3 N0-3 M0 invasive breast cancer in Sweden from 2008 to 2017. Only major surgical postoperative complications leading to readmission and/or reoperation within 30 days were considered. Main outcomes were overall survival (OS) and breast cancer-specific survival (BCSS). Prospectively collected nationwide register data were used. Multivariable Cox models were adjusted for clinical and socioeconomic confounders and co-morbidity.

RESULTS

Among 57 152 women, major surgical postoperative complications were registered for 1854 patients. Median follow-up was 6.22 (0.09-11.70) years. Overall, 9163 patients died, and 3472 died from breast cancer. Major surgical postoperative complications were more common after mastectomy with or without immediate reconstruction (7.3 and 4.3 per cent respectively) than after breast-conserving surgery (2.3 per cent). Unadjusted 5-year OS and BCSS rates were 82.6 (95 per cent c.i. 80.8 to 84.5) and 92.1 (90.8 to 93.5) per cent respectively for women with a major surgical postoperative complication, and 88.8 (88.6 to 89.1) and 95.0 (94.8 to 95.2) per cent for those without a complication (P < 0.001). After adjustment, all-cause and breast cancer mortality rates remained higher after a major surgical postoperative complication (OS: HR 1.32, 95 per cent c.i. 1.15 to 1.51; BCSS: HR 1.31, 1.04 to 1.65). After stratification for type of breast surgery, this association remained significant only for women who had mastectomy without reconstruction (OS: HR 1.41, 1.20 to 1.66; BCSS: HR 1.36, 1.03 to 1.79).

CONCLUSION

Major surgical postoperative complications are associated with inferior survival, especially after mastectomy. These results underline the importance of surgical de-escalation.

摘要

背景

术后并发症可能通过组织损伤、伤口愈合、感染和炎症激活促转移的全身途径。术后并发症与多种类型癌症的生存预后不良有关。本研究旨在确定乳腺癌患者术后并发症与生存之间的关系。

方法

本研究为基于人群的队列研究,纳入了 2008 年至 2017 年在瑞典接受 T1-3N0-3M0 浸润性乳腺癌手术的女性。仅考虑导致 30 天内再次入院和/或再次手术的主要外科术后并发症。主要结局为总生存(OS)和乳腺癌特异性生存(BCSS)。使用前瞻性收集的全国性登记数据。多变量 Cox 模型调整了临床和社会经济混杂因素以及合并症。

结果

在 57152 名女性中,有 1854 名患者记录到主要外科术后并发症。中位随访时间为 6.22(0.09-11.70)年。共有 9163 名患者死亡,其中 3472 人死于乳腺癌。乳房切除术(伴或不伴即刻重建)后的主要外科术后并发症更为常见(分别为 7.3%和 4.3%),而保乳手术后的并发症发生率较低(2.3%)。未经调整的 5 年 OS 和 BCSS 率分别为发生主要外科术后并发症患者为 82.6%(95%置信区间 80.8-84.5)和 92.1%(90.8-93.5),而无并发症患者为 88.8%(88.6-89.1)和 95.0%(94.8-95.2)(P<0.001)。调整后,所有原因和乳腺癌死亡率在发生主要外科术后并发症后仍较高(OS:HR 1.32,95%置信区间 1.15-1.51;BCSS:HR 1.31,1.04-1.65)。按乳房手术类型分层后,仅在未接受乳房重建的乳房切除术患者中,这种关联仍然显著(OS:HR 1.41,1.20-1.66;BCSS:HR 1.36,1.03-1.79)。

结论

主要外科术后并发症与生存预后不良相关,尤其是在乳房切除术患者中。这些结果强调了手术降级的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff85/10364684/37032378429b/znac275f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验